SIBN: SI-BONE Inc Analyst Median Target

Corporate company logo of SI-BONE Corp (SIBN)

The price indicator on the SI-BONE, Inc. (SIBN) chart reflects the dynamics of a company with a consensus of 26.67. The business monetizes proprietary titanium pelvic fixation components while training surgeons globally. Automated production lines ensure high product quality, while R&D remains human-driven. The company achieves cost optimization by outsourcing the fabrication of simple blanks to external partners while maintaining full internal control.

SI-BONE Inc - SIBN Price Target Chart (period 07/04/2022 - 11/11/2026)
Core merchandise of SI-BONE Inc

This indicator synthesizes weighted average expert estimates based on debt load dynamics and balance sheet liquidity. It determines the fair value of the asset through the lens of market expectations and fundamental risks. For SI-BONE, Inc. (SIBN), the growth in the number of procedures using iFuse systems confirms capitalization potential. The consensus projected share price reflects market confidence in the monetization of innovations. Ignoring conservative scenarios in this chart risks underestimating the cash shortfall.

Competing companies

Analyst Median Target bostonscientific.com|Analyst Consensus Forecast EW (Edwards Lifesciences Corporation)|Analyst Median Target ResMed Inc (RMD)|OmniPod - Analyst Consensus Forecast|ZBH: Price Target Chart|The Cooper Companies (COO) - Price Target Chart|Broker Consensus Forecast ALGN|Price Target Chart Globus Medical|TransMedics (TMDX) - Analyst Median Target|Price Target Chart ATEC Spine (ATEC)|AORT: Forecast Levels Chart|Analyst Consensus Forecast ENOV (Enovis Corporation)|integralife.com (IART) - Average Forecast Price|Establishment Labs Holdings Inc. - Analyst Consensus Forecast|Beta Bionics, Inc. (BBNX) - Consensus Target|IRMD: Analyst Consensus Forecast|EMBC - Analyst Median Target|TNDM (Tandem Diabetes Care) - Analyst Consensus Forecast|Analyst Consensus Forecast axogeninc.com|Price Target Chart Orthofix (OFIX)|Price Target Chart BVS (Bioventus Inc)|Analyst Consensus Forecast KIDS (OrthoPediatrics)|Analyst Median Target Treace Corp (TMCI)|SRTA: Consensus Target|Forecast Levels Chart CARL|RXST: Analyst Consensus Forecast|Average Forecast Price ClearPoint Neuro (CLPT)|STXS (Stereotaxis Corp) - Analyst Consensus Forecast|Broker Consensus Forecast STIM (Neuronetics, Inc)|Consensus Target SGHT (Sight Sciences, Inc.)|OBIO (Orchestra BioMed Inc.) - Fair Value Consensus|Price Target Chart Anika Therapeutics, Inc. ANIK|NSPR - Consensus Target|Jin Medical International Ltd - Analyst Consensus Forecast|Average Forecast Price Vivani Medical, Inc.|XTNT: Analyst Consensus Forecast|Broker Consensus Forecast NMTC|MODD (Modular Medical Inc) - Analyst Consensus Forecast|Myomo Inc. (MYO) - Analyst Median Target|Analyst Consensus Forecast COCH|Consensus Target Vivos Therapeutics Inc VVOS|Analyst Consensus Forecast NVNO (enVVeno Medical)|Analyst Consensus Forecast Sintx Technologies Inc SINT|TNON - Price Target Chart|LFWD: Price Target Chart|AMIX (autonomix.com) - Consensus Target|INVO Fertility Corp - Fair Value Consensus|BBLG (Bone Biologics) - Analyst Consensus Forecast|Average Forecast Price axonics.com AXNX|Price Target Chart BIOLASE (BIOL)|dynatronics.com (DYNT) - Analyst Target Range|Paragon 28 - Consensus Target|Analyst Consensus Forecast INVO Bioscience Inc. INVO